Randomness and biospecificity: random copolymers are capable of biospecific molecular recognition in living systems.
暂无分享,去创建一个
[1] R. Larsson,et al. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.
[2] M. Petitou,et al. The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics , 1993 .
[3] A. Poot,et al. The binding of human blood platelets to fibrinogen-, fibronectin-, and Arg-Gly-Asp-derivatized Sephadex G-10. , 1995, Journal of biomaterials science. Polymer edition.
[4] R. Jordan,et al. Fractionation of low molecular weight heparin species and their interaction with antithrombin. , 1979, The Journal of biological chemistry.
[5] A. Hoffman,et al. COVALENT BINDING OF BIOMOLECULES TO RADIATION‐GRAFTED HYDROGELS ON INERT POLYMER SURFACES , 1972, Transactions - American Society for Artificial Internal Organs.
[6] J. Hubbell,et al. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. , 1990, Analytical biochemistry.
[7] S. W. Kim,et al. Immobilized heparin: spacer arm effects on biological interactions. , 1982, Thrombosis research.
[8] T. Tuan,et al. New evidence and new hope concerning endothelial seeding of vascular grafts. , 1992, American journal of surgery.
[9] J. Feijen,et al. Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems , 1996 .
[10] E. Merrill,et al. Polyvinyl alcohol--- heparin hydrogel "G". , 1970, Journal of applied physiology.
[11] J. Courty,et al. Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran. , 1989, Journal of biomaterials science. Polymer edition.
[12] M. Kazatchkine,et al. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. , 1988, Molecular immunology.
[13] D. Letourneur,et al. Inhibition by heparin and derivatized dextrans of Staphylococcus aureus adhesion to fibronectin-coated biomaterials. , 1992, Journal of biomaterials science. Polymer edition.
[14] R. Barbucci,et al. Preparation and ESCA characterization of poly(vinyl chloride) surface-grafted with heparin-complexing poly(amido amine) chains. , 1982, Biomaterials.
[15] R. Schnaar,et al. Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces: support of fibroblast adhesion and long-term growth. , 1988, Analytical biochemistry.
[16] K. Yamada,et al. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function , 1984, The Journal of cell biology.
[17] G. Reach,et al. Reversible morphological and functional abnormalities of RINm5F cells cultured on polystyrene sulfonate beads. , 1987, Journal of biomedical materials research.
[18] A. Fischer,et al. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation. , 1985, Biomaterials.
[19] D. Muller,et al. Affinity chromatography of thrombin on modified polystyrene resins. , 1986, Journal of chromatography.
[20] R. Rosenberg,et al. Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies. , 1983, Biomaterials.
[21] M. Jozefowicz,et al. Randomness and Biospecificity : Random Copolymers are Endowed with Biospecific Properties , 1996 .
[22] J. Brash,et al. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups. , 1988, Biomaterials.
[23] M. Petitou,et al. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.
[24] K. Woodhouse,et al. Interactions of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies. , 1994, Journal of biomedical materials research.
[25] L. Stanislawski,et al. Conformational changes of fibronectin induced by polystyrene derivatives with a heparin-like function. , 1993, Journal of biomedical materials research.
[26] T. Avramoglou,et al. Derivatized dextran inhibition of smooth muscle cell proliferation. , 1991, Journal of biomaterials science. Polymer edition.
[27] R. Rosenberg,et al. Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives. , 1984, Biomaterials.
[28] M. Kazatchkine,et al. Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans. , 1987, Biomaterials.
[29] M. Samama,et al. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins. , 1982, Thrombosis research.
[30] G. Reach,et al. RINm5F cell culture on Sephadex derivatives. , 1993, Journal of biomedical materials research.
[31] B. Ratner,et al. Surface properties of RGD-peptide grafted polyurethane block copolymers: variable take-off angle and cold-stage ESCA studies. , 1993, Journal of biomaterials science. Polymer edition.
[32] J. Brash,et al. Interaction of antithrombin III in purified solution and in plasma with insoluble modified polystyrene , 1993 .
[33] V. Migonney,et al. Heparin-like tubings. I. Preparation, characterization and biological in vitro activity assessment. , 1988, Biomaterials.
[34] M. Sefton,et al. Properties of a heparin-poly(vinyl alcohol) hydrogel coating. , 1983, Journal of biomedical materials research.
[35] M. Kazatchkine,et al. Effect of substituted dextran derivative on complement activation in vivo. , 1995, Biomaterials.
[36] V. Migonney,et al. Biospecific polymers: recognition of phosphorylated polystyrene derivatives by anti-DNA antibodies. , 1997, Journal of biomaterials science. Polymer edition.
[37] M. Mauzac,et al. Antithrombic activity of some polysaccharide resins. , 1982, Biomaterials.
[38] C. Boisson-Vidal,et al. Adsorption of human antibodies to factor VIII:C to insoluble modified polystyrene from plasma , 1991 .
[39] M. Okuno,et al. Fibroblast attachment to Arg-Gly-Asp peptide-immobilized poly(γ-methyl L-glutamate) , 1994 .
[40] J. Apsimon. The Total Synthesis of Natural Products , 1973 .
[41] R. Dutton,et al. Heparin Bonding on Colloidal Graphite Surfaces , 1963, Science.
[42] R. Rosenberg,et al. Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins. , 1984, Biomaterials.
[43] M. Mauzac,et al. Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation. , 1987, Biomaterials.
[44] D. Letourneur,et al. Insoluble DNA-like phosphorylated polystyrene: specific interactions with anti-DNA antibodies from systemic lupus erythematosus patients. , 1992, Biomaterials.
[45] R. Schwartz,et al. Monoclonal anti‐cardiolipin antibodies bind to DNA , 1984, European journal of immunology.
[46] M. Crépin,et al. Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro , 1992, Anti-cancer drugs.
[47] F. Macritchie. Proteins at interfaces. , 1978, Advances in protein chemistry.
[48] D. Muller,et al. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies. , 1994, Journal of biomaterials science. Polymer edition.
[49] D. Barritault,et al. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF , 1992, Journal of cellular physiology.
[50] V. Migonney,et al. DNA‐like and phospholipid‐like phosphorylated polystyrenes: Characterization, distribution of functional groups, and calcium complexation properties , 1994 .
[51] M. Jozefowicz,et al. Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function. , 1983, Biomaterials.
[52] A. Fischer,et al. Antithrombic properties of insoluble modified polystyrene: Part I. , 1984, Thrombosis research.
[53] M. Mauzac,et al. Anticoagulant hydrogels derived from crosslinked dextran. Part I: Synthesis, characterization and antithrombic activity. , 1987, Biomaterials.
[54] Erkki Ruoslahti,et al. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.
[55] D. Stampe,et al. Isolation of factor IX concentrates for clinical use by ion-exchange chromatography and ammonium sulphate precipitation. , 1986, Journal of chromatography.
[56] J. Courty,et al. Affinity chromatography of fibroblast growth factors on substituted polystyrene. , 1990, Journal of chromatography.
[57] A. D. Litmanovich. Change of polymer reactivity in the course of macromolecular reaction , 1980 .
[58] V. Migonney,et al. Heparin-like tubings. II. Mechanism of the thrombin-antithrombin III reaction at the surface. , 1988, Biomaterials.
[59] D. Williams,et al. Biocompatibility of tissue analogs , 1985 .
[60] T. Avramoglou,et al. Inhibitory effect of functional dextrans on rat arterial smooth muscle cell growth in vitro , 1994 .
[61] D. Labarre,et al. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. , 1992, Biomaterials.
[62] V. Migonney,et al. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions. , 1988, Biomaterials.
[63] Y. Sultan,et al. Human umbilical vein endothelial cell culture on heparin-like microcarriers. , 1993, Journal of biomedical materials research.
[64] J. Jozefonvicz,et al. Affinity of antithrombin III for insoluble modified polystyrene. , 1987, Thrombosis research.
[65] J. Andrade,et al. Vroman effects, techniques, and philosophies. , 1991, Journal of biomaterials science. Polymer edition.
[66] D. Labarre,et al. Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic amino acids. , 1987, Biomaterials.
[67] J. Monod. Le hasard et la nécessité , 1970 .
[68] M. Mauzac,et al. Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization. , 1984, Biomaterials.
[69] D. Letourneur,et al. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. , 1993, Journal of biomaterials science. Polymer edition.
[70] M. Kazatchkine,et al. Anticomplementary activity of dextran derivatives. , 1985, Biomaterials.
[71] D. Muller,et al. Thrombin purification by one-step preparative affinity chromatography on modified polystyrenes. , 1986, Journal of chromatography.